Back to results
US 2022/0089567 A1Published application
Rho kinase inhibitor ba-1049 (r) and active metabolites thereof
AssigneeBioAxone BioSciences, Inc.
InventorsKenneth M. ROSEN, Matthew D. ABBINANTI, Joerg RUSCHEL, Lisa MCKERRACHER, Lisa BOND MORITZ
Life of this patent
Estimating the term…
Abstract
BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
Claims5
-36. (canceled)
A method for treating cerebral cavernous malformations (CCM) in a patient in need thereof, the method comprising:
- administering to the patient a therapeutically effective amount of a pharmaceutical formulation comprising an adipate salt of a compound of structure:
Dependencies are inferred from the claim text.